Mechanism of PANoptosis in metabolic dysfunction-associated steatotic liver disease

Area of Science:

• Hepatology
• Cell Biology
• Immunology

Background:

• Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health issue.
• MASLD can progress to metabolic dysfunction-associated steatohepatitis (MASH), cirrhosis, and hepatocellular carcinoma.
• PANoptosis, a form of inflammatory programmed cell death, is implicated in MASLD pathogenesis.

Purpose of the Study:

• To review the current understanding of PANoptosis in MASLD.
• To explore the mechanisms linking PANoptosis to MASH development and liver fibrosis.
• To identify potential therapeutic strategies targeting PANoptosis for MASLD treatment.

Main Methods:

• Literature review of recent research on PANoptosis and MASLD.
• Analysis of studies investigating the role of programmed cell death in liver disease.
• Synthesis of findings on the molecular pathways involved.

Main Results:

• PANoptosis is increasingly recognized as a critical factor in MASH pathogenesis.
• This inflammatory cell death pathway contributes to hepatocyte injury and liver fibrosis.
• Understanding PANoptosis offers novel avenues for drug development.

Conclusions:

• PANoptosis is a key driver in the progression of MASLD to MASH and subsequent liver damage.
• Targeting PANoptosis presents a promising strategy for future MASLD therapies.
• Further research is needed to fully elucidate the therapeutic potential.